THC for Stress (ETS Trial)

Phase < 1

Recruiting

Led By Harriet de Wit

Research Sponsored by University of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age between 18-35 years old

Be between 18 and 65 years old

Must not have

Daily use of medications outside of contraception

History of psychosis or mania

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (5 minutes before memory task) and 20 seconds after each cue presentation during the task

Summary

This trial aims to investigate how THC, a component of cannabinoids, affects how we remember stressful experiences. The researchers believe that THC can reduce our reactions to negative and fearful memories.

Who is the study for?

This trial is for individuals who are interested in how certain drugs might affect stress memories. Specific eligibility criteria details were not provided, so it's unclear who exactly can participate.

What is being tested?

The study is testing the effects of two doses of THC (5mg and 10mg) compared to a placebo on how people respond to stressful memories. Researchers think that THC might help reduce these stress responses.

What are the potential side effects?

While specific side effects aren't listed, common ones from THC may include dizziness, dry mouth, altered senses or mood changes. The exact experiences will vary by individual.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 35 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I take daily medication other than for birth control.

Select...

I have a history of psychosis or mania.

Select...

I am pregnant or trying to become pregnant.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (5 minutes before memory task) and 20 seconds after each cue presentation during the task

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (5 minutes before memory task) and 20 seconds after each cue presentation during the task

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (5 minutes before memory task) and 20 seconds after each cue presentation during the task for reporting.